3 different filers disclosed IQV within 90 days. Disclosed 18 days after the transaction; reported as an official range, not an exact amount.
Traded Dec 18, 2025 · Filed Dec 19, 2025
A board member of IQVIA sold $8.13M of IQVIA shares. Nobody planned it ahead of time.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$8,132,931
Shares × reported transaction price
51 days after results of Oct 28, 2025, 49 days before results of Feb 5, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $222.52 on Dec 18, 2025, within 5% of its 52-week high, after a 6% rise over the previous 30 trading days
52-week range $137.00 (May 23, 2025) to $231.92 (Nov 25, 2025), 90% of the way up, from 250 adjusted closes. 30 trading days earlier: $210.12 on Nov 5, 2025. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +1.2% | +0.4% | +0.8% |
| 30 days | +7.6% | +0.1% | +7.5% |
| 90 days | -25.6% | -4.3% | -21.3% |
| 180 days | -25.2% | +8.7% | -33.9% |
Past results only. Not a forecast.
3 different filers disclosed IQV within 90 days. Disclosed 18 days after the transaction; reported as an official range, not an exact amount.
Derivative exercise or conversion — not an open-market buy.
Not classified as an open-market trade.